Argentina joined Peru, Morocco and the United Arab Emirates in approving Phase 3 clinical trials for a coronavirus vaccine developed by China National Biotec Group (CNBG), the company said late Friday.
As China forges ahead in the global race to develop a vaccine to curb the COVID-19 pandemic and as cases within China dwindle, CNBG needs research participants from other countries for testing.
Read the latest updates in our dedicated coronavirus section.
Phase 3 trials, which usually involve several thousand participants, allow researchers to gather data on the efficacy of potential vaccines for final regulatory approvals.
Coronavirus: WHO begins talks with Russia about COVID-19 vaccine
UAE’s G42 to work with Israeli NanoScent to develop COVID-19 detector from scent
CNBG will partner with Argentina’s ELEA in the vaccine trial, the Chinese company said in a statement late Friday.
For all the latest headlines, follow our Google News channel online or via the app.
The experimental vaccine by CNBG, a unit of state-owned pharmaceutical giant China National Pharmaceutical Group (Sinopharm), received approval from the UAE in June for a Phase 3 trial and has since recruited 15,000 volunteers.
The company said on Thursday that Peru and Morocco also approved the trials.
CNBG has also obtained approval from Bahrain for a Phase 3 study designed to involve around 6,000 participants.
Watch: Sanitizing booths in Argentina to stop coronavirus spread in low income areasNeighbors in the Padre Rodolfo Ricciardelli neighborhood, a low-income locality of Buenos Aires, have built sanitizing booths to disinfect themselves ... Coronavirus
Coronavirus: Despite travel bans, Argentina to fly in rabbis to certify kosher meatArgentina, which has enforced one of the world’s toughest travel bans against the coronavirus, plans to help charter a private flight to bring in ... Coronavirus
Latin America’s first coronavirus fatality is in ArgentinaA 64-year-old man died of the novel coronavirus Saturday in Argentina, authorities said, making him Latin America's first fatality in the global ... World News